HEADER SIGNALING PROTEIN 26-FEB-20 6Y6B TITLE CRYSTAL STRUCTURE OF HUMAN 14-3-3 GAMMA IN COMPLEX WITH CAMKK2 14-3-3 TITLE 2 BINDING MOTIF SER100 AND 16-OME-FUSICOCCIN H COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN KINASE C INHIBITOR PROTEIN 1,KCIP-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: CAMKK 2,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE COMPND 10 BETA,CAMKK BETA; COMPND 11 EC: 2.7.11.17; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS 14-3-3 PROTEIN, COMPLEX, CAMKK, FUSICOCCIN, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.LENTINI SANTO,V.OBSILOVA,T.OBSIL REVDAT 2 24-JAN-24 6Y6B 1 REMARK REVDAT 1 03-FEB-21 6Y6B 0 JRNL AUTH D.LENTINI SANTO,O.PETRVALSKA,V.OBSILOVA,C.OTTMANN,T.OBSIL JRNL TITL STABILIZATION OF PROTEIN-PROTEIN INTERACTIONS BETWEEN CAMKK2 JRNL TITL 2 AND 14-3-3 BY FUSICOCCINS. JRNL REF ACS CHEM.BIOL. V. 15 3060 2020 JRNL REFN ESSN 1554-8937 JRNL PMID 33146997 JRNL DOI 10.1021/ACSCHEMBIO.0C00821 REMARK 2 REMARK 2 RESOLUTION. 3.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17_3644 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.08 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.244 REMARK 3 R VALUE (WORKING SET) : 0.242 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1039 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 17.7500 - 5.8300 1.00 2982 158 0.1899 0.2147 REMARK 3 2 5.8300 - 4.6500 1.00 2841 149 0.2380 0.2913 REMARK 3 3 4.6500 - 4.0700 1.00 2814 148 0.2260 0.2756 REMARK 3 4 4.0700 - 3.7100 1.00 2788 147 0.2673 0.3032 REMARK 3 5 3.7100 - 3.4400 1.00 2776 146 0.3122 0.3359 REMARK 3 6 3.4400 - 3.2400 1.00 2766 146 0.3698 0.4454 REMARK 3 7 3.2400 - 3.0800 1.00 2746 145 0.3995 0.4276 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.466 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.951 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 110.2 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 113.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.001 3722 REMARK 3 ANGLE : 0.357 5063 REMARK 3 CHIRALITY : 0.030 592 REMARK 3 PLANARITY : 0.002 650 REMARK 3 DIHEDRAL : 8.645 528 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6Y6B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1292106967. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20904 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.080 REMARK 200 RESOLUTION RANGE LOW (A) : 48.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 21.72 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 22.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.690 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2B05 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG400, HEPES, MAGNESIUM CHLORIDE, REMARK 280 HEXAFLUOROPROPANOL, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z+1/2 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 36.49650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 36.49650 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 36.49650 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 36.49650 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 36.49650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 36.49650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 71 REMARK 465 ALA A 72 REMARK 465 ASP A 73 REMARK 465 GLY A 74 REMARK 465 ASN A 75 REMARK 465 GLU A 76 REMARK 465 THR A 234 REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ARG C 97 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 2 CG1 CG2 REMARK 470 LEU A 13 CG CD1 CD2 REMARK 470 LYS A 69 CG CD CE NZ REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 ARG A 83 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 LYS A 142 CG CD CE NZ REMARK 470 GLU A 148 CG CD OE1 OE2 REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 LYS A 198 CG CD CE NZ REMARK 470 LEU A 208 CG CD1 CD2 REMARK 470 LEU A 211 CG CD1 CD2 REMARK 470 GLU A 213 CG CD OE1 OE2 REMARK 470 ASP A 214 CG OD1 OD2 REMARK 470 SER A 215 OG REMARK 470 TYR A 216 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 217 CG CD CE NZ REMARK 470 LEU A 221 CG CD1 CD2 REMARK 470 LEU A 232 CG CD1 CD2 REMARK 470 VAL B 2 CG1 CG2 REMARK 470 GLU B 5 CG CD OE1 OE2 REMARK 470 GLN B 6 CG CD OE1 NE2 REMARK 470 GLN B 68 CG CD OE1 NE2 REMARK 470 SER B 71 OG REMARK 470 ASP B 73 CG OD1 OD2 REMARK 470 ASN B 75 CG OD1 ND2 REMARK 470 GLU B 76 CG CD OE1 OE2 REMARK 470 LYS B 77 CG CD CE NZ REMARK 470 LYS B 78 CG CD CE NZ REMARK 470 ARG B 83 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 91 CG CD CE NZ REMARK 470 LYS B 110 CG CD CE NZ REMARK 470 GLU B 114 CG CD OE1 OE2 REMARK 470 LYS B 120 CG CD CE NZ REMARK 470 LYS B 127 CG CD CE NZ REMARK 470 LYS B 142 CG CD CE NZ REMARK 470 GLU B 148 CG CD OE1 OE2 REMARK 470 LYS B 152 CG CD CE NZ REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 PHE B 182 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR B 183 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 191 CG CD OE1 OE2 REMARK 470 GLN B 192 CG CD OE1 NE2 REMARK 470 ASN B 212 CG OD1 ND2 REMARK 470 GLU B 213 CG CD OE1 OE2 REMARK 470 ASP B 214 CG OD1 OD2 REMARK 470 LYS B 217 CG CD CE NZ REMARK 470 ARG B 227 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 98 CG CD CE NZ REMARK 470 ARG C 104 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 97 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 98 CG CD CE NZ REMARK 470 ARG D 104 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 138 149.78 -171.45 REMARK 500 HIS B 164 51.55 -95.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OD8 B 301 DBREF 6Y6B A 1 234 UNP P61981 1433G_HUMAN 1 234 DBREF 6Y6B B 1 234 UNP P61981 1433G_HUMAN 1 234 DBREF 6Y6B C 97 104 UNP Q96RR4 KKCC2_HUMAN 97 104 DBREF 6Y6B D 97 104 UNP Q96RR4 KKCC2_HUMAN 97 104 SEQADV 6Y6B GLY A -1 UNP P61981 EXPRESSION TAG SEQADV 6Y6B HIS A 0 UNP P61981 EXPRESSION TAG SEQADV 6Y6B GLY B -1 UNP P61981 EXPRESSION TAG SEQADV 6Y6B HIS B 0 UNP P61981 EXPRESSION TAG SEQRES 1 A 236 GLY HIS MET VAL ASP ARG GLU GLN LEU VAL GLN LYS ALA SEQRES 2 A 236 ARG LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP MET ALA SEQRES 3 A 236 ALA ALA MET LYS ASN VAL THR GLU LEU ASN GLU PRO LEU SEQRES 4 A 236 SER ASN GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS SEQRES 5 A 236 ASN VAL VAL GLY ALA ARG ARG SER SER TRP ARG VAL ILE SEQRES 6 A 236 SER SER ILE GLU GLN LYS THR SER ALA ASP GLY ASN GLU SEQRES 7 A 236 LYS LYS ILE GLU MET VAL ARG ALA TYR ARG GLU LYS ILE SEQRES 8 A 236 GLU LYS GLU LEU GLU ALA VAL CYS GLN ASP VAL LEU SER SEQRES 9 A 236 LEU LEU ASP ASN TYR LEU ILE LYS ASN CYS SER GLU THR SEQRES 10 A 236 GLN TYR GLU SER LYS VAL PHE TYR LEU LYS MET LYS GLY SEQRES 11 A 236 ASP TYR TYR ARG TYR LEU ALA GLU VAL ALA THR GLY GLU SEQRES 12 A 236 LYS ARG ALA THR VAL VAL GLU SER SER GLU LYS ALA TYR SEQRES 13 A 236 SER GLU ALA HIS GLU ILE SER LYS GLU HIS MET GLN PRO SEQRES 14 A 236 THR HIS PRO ILE ARG LEU GLY LEU ALA LEU ASN TYR SER SEQRES 15 A 236 VAL PHE TYR TYR GLU ILE GLN ASN ALA PRO GLU GLN ALA SEQRES 16 A 236 CYS HIS LEU ALA LYS THR ALA PHE ASP ASP ALA ILE ALA SEQRES 17 A 236 GLU LEU ASP THR LEU ASN GLU ASP SER TYR LYS ASP SER SEQRES 18 A 236 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 19 A 236 TRP THR SEQRES 1 B 236 GLY HIS MET VAL ASP ARG GLU GLN LEU VAL GLN LYS ALA SEQRES 2 B 236 ARG LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP MET ALA SEQRES 3 B 236 ALA ALA MET LYS ASN VAL THR GLU LEU ASN GLU PRO LEU SEQRES 4 B 236 SER ASN GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS SEQRES 5 B 236 ASN VAL VAL GLY ALA ARG ARG SER SER TRP ARG VAL ILE SEQRES 6 B 236 SER SER ILE GLU GLN LYS THR SER ALA ASP GLY ASN GLU SEQRES 7 B 236 LYS LYS ILE GLU MET VAL ARG ALA TYR ARG GLU LYS ILE SEQRES 8 B 236 GLU LYS GLU LEU GLU ALA VAL CYS GLN ASP VAL LEU SER SEQRES 9 B 236 LEU LEU ASP ASN TYR LEU ILE LYS ASN CYS SER GLU THR SEQRES 10 B 236 GLN TYR GLU SER LYS VAL PHE TYR LEU LYS MET LYS GLY SEQRES 11 B 236 ASP TYR TYR ARG TYR LEU ALA GLU VAL ALA THR GLY GLU SEQRES 12 B 236 LYS ARG ALA THR VAL VAL GLU SER SER GLU LYS ALA TYR SEQRES 13 B 236 SER GLU ALA HIS GLU ILE SER LYS GLU HIS MET GLN PRO SEQRES 14 B 236 THR HIS PRO ILE ARG LEU GLY LEU ALA LEU ASN TYR SER SEQRES 15 B 236 VAL PHE TYR TYR GLU ILE GLN ASN ALA PRO GLU GLN ALA SEQRES 16 B 236 CYS HIS LEU ALA LYS THR ALA PHE ASP ASP ALA ILE ALA SEQRES 17 B 236 GLU LEU ASP THR LEU ASN GLU ASP SER TYR LYS ASP SER SEQRES 18 B 236 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 19 B 236 TRP THR SEQRES 1 C 8 ARG LYS LEU SEP LEU GLN GLU ARG SEQRES 1 D 8 ARG LYS LEU SEP LEU GLN GLU ARG MODRES 6Y6B SEP C 100 SER MODIFIED RESIDUE MODRES 6Y6B SEP D 100 SER MODIFIED RESIDUE HET SEP C 100 10 HET SEP D 100 10 HET OD8 B 301 35 HETNAM SEP PHOSPHOSERINE HETNAM OD8 (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(HYDROXYMETHYL)-6- HETNAM 2 OD8 [[(1~{S},3~{R},6~{S},7~{S},8~{R},9~{R},10~{R},11~{R}, HETNAM 3 OD8 14~{S})-14-(ME THOXYMETHYL)-3,10-DIMETHYL-9-OXIDANYL- HETNAM 4 OD8 6-PROPAN-2-YL-8-TRICYCLO[9.3.0.0^{3, HETNAM 5 OD8 7}]TETRADECANYL]OXY]OXANE-3,4,5-TRIOL HETSYN SEP PHOSPHONOSERINE HETSYN OD8 16-OME-FUSICOCCIN H FORMUL 3 SEP 2(C3 H8 N O6 P) FORMUL 5 OD8 C27 H48 O8 HELIX 1 AA1 ASP A 3 ALA A 17 1 15 HELIX 2 AA2 ARG A 19 GLU A 32 1 14 HELIX 3 AA3 SER A 38 THR A 70 1 33 HELIX 4 AA4 LYS A 78 TYR A 107 1 30 HELIX 5 AA5 GLN A 116 GLU A 136 1 21 HELIX 6 AA6 GLY A 140 HIS A 164 1 25 HELIX 7 AA7 HIS A 169 ILE A 186 1 18 HELIX 8 AA8 ALA A 189 GLU A 207 1 19 HELIX 9 AA9 TYR A 216 TRP A 233 1 18 HELIX 10 AB1 ASP B 3 ALA B 17 1 15 HELIX 11 AB2 ARG B 19 GLU B 32 1 14 HELIX 12 AB3 SER B 38 THR B 70 1 33 HELIX 13 AB4 GLU B 76 TYR B 107 1 32 HELIX 14 AB5 GLN B 116 VAL B 137 1 22 HELIX 15 AB6 GLY B 140 HIS B 164 1 25 HELIX 16 AB7 HIS B 169 ILE B 186 1 18 HELIX 17 AB8 ALA B 189 ALA B 206 1 18 HELIX 18 AB9 GLU B 207 LEU B 211 5 5 HELIX 19 AC1 TYR B 216 THR B 234 1 19 LINK C LEU C 99 N SEP C 100 1555 1555 1.33 LINK C SEP C 100 N LEU C 101 1555 1555 1.33 LINK C LEU D 99 N SEP D 100 1555 1555 1.33 LINK C SEP D 100 N LEU D 101 1555 1555 1.33 SITE 1 AC1 8 ASN B 43 VAL B 47 PHE B 122 LYS B 125 SITE 2 AC1 8 MET B 126 PRO B 170 ASP B 218 GLU D 103 CRYST1 226.266 226.266 72.993 90.00 90.00 120.00 P 63 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004420 0.002552 0.000000 0.00000 SCALE2 0.000000 0.005103 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013700 0.00000